ATE382688T1 - Reinigung einer tripelhelixformation mittels eines immobilisierten oligonukleotides - Google Patents

Reinigung einer tripelhelixformation mittels eines immobilisierten oligonukleotides

Info

Publication number
ATE382688T1
ATE382688T1 AT01937755T AT01937755T ATE382688T1 AT E382688 T1 ATE382688 T1 AT E382688T1 AT 01937755 T AT01937755 T AT 01937755T AT 01937755 T AT01937755 T AT 01937755T AT E382688 T1 ATE382688 T1 AT E382688T1
Authority
AT
Austria
Prior art keywords
purification
triple helix
helix formation
immobilized oligonucleotide
dna
Prior art date
Application number
AT01937755T
Other languages
English (en)
Inventor
Joel Crouzet
Daniel Scherman
Pierre Wils
Francis Blanche
Beatrice Cameron
Original Assignee
Centelion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/580,923 external-priority patent/US6319672B1/en
Application filed by Centelion filed Critical Centelion
Application granted granted Critical
Publication of ATE382688T1 publication Critical patent/ATE382688T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6839—Triple helix formation or other higher order conformations in hybridisation assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01937755T 2000-05-26 2001-05-25 Reinigung einer tripelhelixformation mittels eines immobilisierten oligonukleotides ATE382688T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/580,923 US6319672B1 (en) 1994-12-16 2000-05-26 Purification of a triple helix formation with an immobilized oligonucleotide

Publications (1)

Publication Number Publication Date
ATE382688T1 true ATE382688T1 (de) 2008-01-15

Family

ID=24323138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01937755T ATE382688T1 (de) 2000-05-26 2001-05-25 Reinigung einer tripelhelixformation mittels eines immobilisierten oligonukleotides

Country Status (22)

Country Link
EP (1) EP1290156B1 (de)
JP (1) JP4803945B2 (de)
KR (1) KR100853040B1 (de)
CN (1) CN1446258B (de)
AT (1) ATE382688T1 (de)
AU (3) AU6345901A (de)
BR (1) BR0111145B1 (de)
CA (1) CA2410263C (de)
CZ (1) CZ303086B6 (de)
DE (1) DE60132200T2 (de)
DK (1) DK1290156T3 (de)
ES (1) ES2298239T3 (de)
HU (1) HU228891B1 (de)
IL (2) IL152860A0 (de)
MX (1) MXPA02011463A (de)
NO (1) NO330571B1 (de)
NZ (1) NZ522860A (de)
PT (1) PT1290156E (de)
RU (1) RU2315104C2 (de)
SK (1) SK287662B6 (de)
WO (1) WO2001092511A2 (de)
ZA (1) ZA200209579B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ549835A (en) * 2004-04-19 2008-12-24 Centelion Method for purifying plasmid DNA
PL1737945T3 (pl) * 2004-04-19 2011-07-29 Aventis Pharma Sa Sposób oczyszczania plazmidowego DNA
WO2017186815A1 (en) * 2016-04-26 2017-11-02 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for enhanced expression of frataxin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681940A (en) * 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
FR2728264B1 (fr) 1994-12-16 1997-01-31 Rhone Poulenc Rorer Sa Purification d'adn par formation de triple helice avec un oligonucleotide immobilise
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
FR2746412B1 (fr) * 1996-03-21 1998-06-12 Rhone Poulenc Rorer Sa Purification d'adn plasmidique de qualite pharmaceutique
JP2002507429A (ja) * 1998-03-24 2002-03-12 アバンテイス・フアルマ・エス・アー 核酸導入ベクター、該ベクターを含有する組成物及びそれらの使用

Also Published As

Publication number Publication date
DE60132200T2 (de) 2008-12-18
AU2007202804A1 (en) 2007-07-12
HU228891B1 (en) 2013-06-28
PT1290156E (pt) 2008-02-21
ZA200209579B (en) 2003-10-15
EP1290156A2 (de) 2003-03-12
CZ303086B6 (cs) 2012-03-28
CN1446258A (zh) 2003-10-01
CA2410263A1 (en) 2001-12-06
AU2007202804B2 (en) 2011-04-07
CA2410263C (en) 2014-02-04
EP1290156B1 (de) 2008-01-02
IL196444A (en) 2011-05-31
ES2298239T3 (es) 2008-05-16
PL359265A1 (en) 2004-08-23
NO20025567L (no) 2003-01-23
KR100853040B1 (ko) 2008-08-19
CZ20023865A3 (cs) 2003-04-16
AU6345901A (en) 2001-12-11
AU2001263459B2 (en) 2007-03-15
BR0111145B1 (pt) 2013-06-04
NZ522860A (en) 2004-09-24
RU2315104C2 (ru) 2008-01-20
WO2001092511A3 (en) 2002-04-11
KR20030027894A (ko) 2003-04-07
SK16602002A3 (sk) 2003-06-03
JP4803945B2 (ja) 2011-10-26
BR0111145A (pt) 2003-04-15
HUP0302565A2 (hu) 2003-10-28
SK287662B6 (sk) 2011-05-06
HUP0302565A3 (en) 2010-01-28
NO330571B1 (no) 2011-05-16
IL152860A0 (en) 2003-06-24
DE60132200D1 (de) 2008-02-14
DK1290156T3 (da) 2008-05-13
AU2007202804B8 (en) 2011-07-14
JP2003534799A (ja) 2003-11-25
MXPA02011463A (es) 2004-09-06
CN1446258B (zh) 2013-01-09
NO20025567D0 (no) 2002-11-20
WO2001092511A2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
MX9703670A (es) Purificacion de adn mediante la formacion de triple helice con un oligonucleotido inmovilizado.
DE59803203D1 (de) Formkörper und verfahren zu dessen herstellung
TWI265048B (en) Modified catalysts and process
MY139589A (en) Aromatization catalyst and methods of making and using same
WO2009135093A3 (en) Rnase-h-based assays utilizing modified rna monomers
ATE283238T1 (de) Verfahren zur herstellung kugelförmiger aktivkohle
NZ600183A (en) Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
DK2284266T3 (da) sIRNA-MOLEKYLE MOD TP53
DE60227525D1 (de) Verfahren zur Herstellung von Nukleinsäuremolekülen
DE602006017192D1 (de) Verfahren zur herstellung von oligonukleotiden
ATE382688T1 (de) Reinigung einer tripelhelixformation mittels eines immobilisierten oligonukleotides
CN108642092B (zh) 一种强化抗生素厌氧降解的方法
CN104671425B (zh) 一种人工湿地专用填料微生物固定化方法
EA201101179A1 (ru) Молекула нуклеиновой кислоты биосинтетического кластера, кодирующая нерибосомальные пептидсинтазы, и ее применение
CN101708892A (zh) 一种用于煤化工废水的深度处理方法
DK2041281T3 (da) Fremgangsmåde til parallel isolering af dobbelt- og enkeltstrengede nukleinsyrer samt til selektiv fjernelse af dobbeltstrengede nukleinsyrer fra en blanding af dobbelt- og enkeltstrengede nukleinsyrer
DE60115849D1 (de) Methode und katalytisches system zur stereoselektiven invertierung eines chiralen zentrums in einer chemischen verbindung
DE60333402D1 (de) Katalytisches verfahren zur herstellung von isolongifolen
BR0004000A (pt) Processo para a preparação fermentativa de ácido d-pantotênico usando bactéria corineforme
ATE478149T1 (de) Verfahren zur gewinnung von indolocarbazolen mit hilfe von rebeccamycin-biosynthesegenen
ATE340196T1 (de) Verfahren zur herstellung einer härtbaren wässrigen polymerdispersion
WO2009044782A1 (ja) 一本鎖又は二本鎖dnaの合成方法および合成キット
RU2002135091A (ru) Очистка трехспиральной структуры с помощью иммобилизованного олигонуклеотида
WO2004050604A3 (en) Process for preparing terbinafine by using platinum as catalyst
RU2006127408A (ru) Rhodococcus erythropolis lg12, обладающий способностью разрушать акриловую кислоту, и способ для удаления акриловой кислоты с его использованием

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1290156

Country of ref document: EP